Commentary

Effective but inaccessible antiobesity medications: A call for sharing responsibility for improving access to evidence-based care

Bartolome Burguera, MD, PhD, Marcio L. Griebeler, MD and W. Timothy Garvey, MD
Cleveland Clinic Journal of Medicine November 2024, 91 (11) 671-676; DOI: https://doi.org/10.3949/ccjm.91a.24068

Article Information

vol. 91 no. 11 671-676
DOI 
https://doi.org/10.3949/ccjm.91a.24068
PubMed 
39486846
Published By 
Cleveland Clinic Journal of Medicine
Print ISSN 
0891-1150
Online ISSN 
1939-2869
History 
  • Published online November 1, 2024.
Copyright & Usage 
Copyright © 2024 The Cleveland Clinic Foundation. All Rights Reserved.

Author Information

  1. Bartolome Burguera, MD, PhD⇑
  1. Chief, Medical Specialty Institute, Cleveland Clinic, Cleveland, OH; Chair, Department of Endocrinology and Metabolism, Cleveland Clinic, Cleveland, OH; Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH
  1. Address:
    Bartolome Burguera, MD, PhD, Medical Specialty Institute, F20, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; burgueb{at}ccf.org
  1. Marcio L. Griebeler, MD
  1. Department of Endocrinology and Metabolism, Cleveland Clinic, Cleveland, OH; Assistant Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH
  1. W. Timothy Garvey, MD
  1. Associate Director, Department of Nutrition Sciences and the University of Alabama at Birmingham Diabetes Research Center, University of Alabama at Birmingham, Birmingham AL; Professor, University of Alabama at Birmingham, Birmingham AL

Cited By...

Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Subjects